Finance

Lists
OCUL:NASDAQ
Ocular Therapeutix Inc
US$6.67
+1.14%
(+0.075) 1D
ኖቬም 9, 11:54:34 ጥዋት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OCUL...
Open
US$6.25
High
US$6.68
Low
US$6.05
Mkt. cap
1.46 ቢ
Avg. vol.
3.64 ሚ
Volume
1.37 ሚ
52-wk high
US$16.44
52-wk low
US$6.00
EPS
-US$1.41
Beta
1.22
Shares outstanding
219.62 ሚ
No. of employees
325
Open
US$6.25
High
US$6.68
Low
US$6.05
Mkt. cap
1.46 ቢ
Avg. vol.
3.64 ሚ
Volume
1.37 ሚ
52-wk high
US$16.44
52-wk low
US$6.00
EPS
-US$1.41
Beta
1.22
Shares outstanding
219.62 ሚ
No. of employees
325
News stories
From web sources and news partners
Yahoo Finance Singapore
Yahoo Finance Singapore
·
ከ1 ሰዓት በፊት
Ocular Therapeutix falls on third quarter earnings miss
Investing.com
Investing.com
·
ከ1 ሰዓት በፊት
Why is Ocular Therapeutix stock sliding today?
Benzinga
Benzinga
·
ከ2 ሰዓቶች በፊት
Ocular Therapeutix Q3 2026 Earnings Call Transcript
About Ocular Therapeutix Inc
CEOPravin Dugel
Employees325
Founded2006
HeadquartersBedford, ማሣቹሰትስ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryPharmaceutical industry
Websiteocutx.com
Analyst ratings
Based on 7 analysts giving stock ratings to OCUL in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for OCUL in the last 3 months.
Highest
Current US$6.67
US$31.00 (+364.77%)
Average
US$23.83 (+257.27%)
Lowest
US$14.00 (+109.90%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
US$25.00
+274.8%
10/20/2026
Tazeen Ahmad
Bank of America Securities
Buy
Maintained
US$27.00
+304.8%
10/13/2026
Biren Amin
Piper Sandler
Buy
Maintained
US$31.00
+364.8%
10/12/2026
Unknown Analyst
UBS
Buy
Initiated
US$14.00
+109.9%
10/11/2026
Alice Nettleton
UBS
Buy
Initiated
US$14.00
+109.9%
10/11/2026
Serge Belanger
Needham
Buy
Maintained
US$18.00
+169.9%
09/28/2026
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
09/25/2026
William Maughan
Clear Street
Buy
Reiterated
US$28.00
+319.8%
08/18/2026
Tara Bancroft
TD Cowen
Buy
Maintained
US$20.00
+199.9%
08/03/2026
Lisa Walter
RBC Capital
Buy
Maintained
US$30.00
+349.8%
08/03/2026
Daniil Gataulin
Chardan Capital
Buy
Maintained
US$23.00
+244.8%
06/25/2026
Colleen M. Kusy
Robert W. Baird
Buy
Maintained
US$30.00
+349.8%
06/18/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
-
-
02/17/2026
Clara Dong
Jefferies
Buy
Maintained
US$28.00
+319.8%
02/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ሴፕቴ 2025
ዲሴም 2025
ማርች 2026
ጁን 2026
Revenue
14.54 ሚ
13.25 ሚ
10.78 ሚ
13.48 ሚ
Cost of goods sold
54.13 ሚ
52.39 ሚ
67.54 ሚ
56.15 ሚ
Cost of revenue
54.13 ሚ
52.39 ሚ
67.54 ሚ
56.15 ሚ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29.11 ሚ
30.62 ሚ
36.58 ሚ
39.44 ሚ
Operating expense
29.11 ሚ
30.62 ሚ
36.58 ሚ
39.44 ሚ
Total operating expenses
83.24 ሚ
83.01 ሚ
104.12 ሚ
95.58 ሚ
Operating income
-68.70 ሚ
-69.76 ሚ
-93.34 ሚ
-82.11 ሚ
Other non operating income
-1.45 ሚ
624.00 ሺ
1.46 ሚ
689.00 ሺ
EBT including unusual items
-69.42 ሚ
-64.65 ሚ
-88.61 ሚ
-78.76 ሚ
EBT excluding unusual items
-69.42 ሚ
-64.62 ሚ
-88.61 ሚ
-78.76 ሚ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-69.42 ሚ
-64.65 ሚ
-88.61 ሚ
-78.76 ሚ
Net profit margin
-477.30%
-487.95%
-821.62%
-584.51%
Earnings per share
-0.38
-0.29
-0.40
-0.35
Interest and investment income
3.73 ሚ
7.34 ሚ
6.05 ሚ
5.45 ሚ
Interest expense
-3.00 ሚ
-2.83 ሚ
-2.78 ሚ
-2.79 ሚ
Net interest expenses
727.00 ሺ
4.51 ሚ
3.27 ሚ
2.66 ሚ
Depreciation and amortization charges
-
-
-
-
EBITDA
-67.63 ሚ
-68.51 ሚ
-92.06 ሚ
-80.26 ሚ
Gain or loss from assets sale
-
-
4.87 ሚ
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google መተግበሪያዎች